Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Usefulness of the genetic study in the diagnosis of medullary carcinoma of the thyroid].

Medicina clinica - 14 Nov 1998

Rafecas A, Ribas Y, Villabona C, Viladrich M, Figueras J, Fabregat J, Torras J, Gómez J M, Jaurrieta E

Abstract excerpt

Germ-line mutations in the RET proto-oncogene are associated with multiple endocrine neoplasia type 2A (MEN 2A) and with familial medullary thyroid carcinoma (FMTC). Detection of these mutations allows the identification of the affected kindred members, who will develop medullary thyroid carcinom...

Topics

Adult
Carcinoma, Medullary
Female
Humans
Male
Middle Aged
Mutation
Pedigree
Proto-Oncogene Mas
Thyroid Neoplasms

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 9881336

Genes

RET

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-9881336-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Usefulness of the genetic study in the diagnosis of medullary carcinoma of the thyroid].PMID 9881336Read ↗

[Study of RET protooncogene in multiple endocrine neoplasm 2A and in familial medullary thyroid carcinoma. Clinical pathological findings in asymptomatic carriers].Semantic proximity Read ↗

[Genetic testing for ret mutation for early diagnosis and treatment in familial medullary thyroid carcinoma: a case report].Semantic proximity Read ↗

[Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].Semantic proximity Read ↗

[Early therapeutic management of patients genetically predisposed to medullary thyroid cancer].Semantic proximity Read ↗

Genetic testing in the diagnosis and management of multiple endocrine neoplasia type II.Semantic proximity Read ↗

[Medullary thyroid cancer: how tumor markers and genetics determine preventive measures].Semantic proximity Read ↗

[The RET gene and medullary thyroid cancer: from mutations to the planning of therapy].Semantic proximity Read ↗

[RET pro-oncogene and medullary thyroid carcinoma].Semantic proximity Read ↗

[Phenotype of the C634Y mutation in the RET proto-oncogene in MEN2A: report of a family].Semantic proximity Read ↗

[Characterization of RET proto-oncogene C634Y mutation in a Moroccan family with multiple endocrine neoplasia type 2A].Semantic proximity Read ↗

[Medullary cancer of the thyroid].Semantic proximity Read ↗

Medullary thyroid carcinoma. Genetic screening and prophylactic thyroidectomies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.